- Home
- CLSD vs LRE Comparison
CLSD vs LRE Comparison
Compare CLSD & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- LRE
- Stock Information
- Founded
- CLSD 2011
- LRE 2001
- Country
- CLSD United States
- LRE Japan
- Employees
- CLSD N/A
- LRE N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- CLSD Health Care
- LRE
- Exchange
- CLSD Nasdaq
- LRE Nasdaq
- Market Cap
- CLSD 20.4M
- LRE 20.5M
- IPO Year
- CLSD 2016
- LRE 2023
- Fundamental
- Price
- CLSD $3.68
- LRE $1.63
- Analyst Decision
- CLSD Hold
- LRE
- Analyst Count
- CLSD 4
- LRE 0
- Target Price
- CLSD $65.00
- LRE N/A
- AVG Volume (30 Days)
- CLSD 29.9K
- LRE 133.0K
- Earning Date
- CLSD 11-07-2025
- LRE 01-01-0001
- Dividend Yield
- CLSD N/A
- LRE N/A
- EPS Growth
- CLSD N/A
- LRE N/A
- EPS
- CLSD N/A
- LRE N/A
- Revenue
- CLSD $4,166,000.00
- LRE $110,330,328.00
- Revenue This Year
- CLSD $98.20
- LRE N/A
- Revenue Next Year
- CLSD $213.77
- LRE N/A
- P/E Ratio
- CLSD N/A
- LRE N/A
- Revenue Growth
- CLSD N/A
- LRE 3.92
- 52 Week Low
- CLSD $3.32
- LRE $1.00
- 52 Week High
- CLSD $17.40
- LRE $2.97
- Technical
- Relative Strength Index (RSI)
- CLSD 51.21
- LRE 51.88
- Support Level
- CLSD $3.68
- LRE $1.32
- Resistance Level
- CLSD $4.08
- LRE $1.74
- Average True Range (ATR)
- CLSD 0.26
- LRE 0.15
- MACD
- CLSD -0.13
- LRE 0.02
- Stochastic Oscillator
- CLSD 2.86
- LRE 57.40
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.